ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,197.62
0.39%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bellicum Pharmaceuticals Inc (BLCM)

  7. Bellicum Pharmaceuticals Inc (BLCM) Noticias

BLCM

Bellicum Pharmaceuticals (BLCM)

Bellicum Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BLCM
FechaHoraFuenteTítuloSímboloCompañía
23/02/202412:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202412:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202417:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLCMBellicum Pharmaceuticals Inc
30/01/202415:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLCMBellicum Pharmaceuticals Inc
30/05/202315:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/05/202315:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLCMBellicum Pharmaceuticals Inc
05/05/202315:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLCMBellicum Pharmaceuticals Inc
31/03/202315:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/03/202315:30GlobeNewswire Inc.Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesNASDAQ:BLCMBellicum Pharmaceuticals Inc
16/02/202306:30GlobeNewswire Inc.Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumNASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202311:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BLCMBellicum Pharmaceuticals Inc
31/01/202317:43GlobeNewswire Inc.CORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLCMBellicum Pharmaceuticals Inc
31/01/202315:36GlobeNewswire Inc.Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLCMBellicum Pharmaceuticals Inc
20/01/202313:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BLCMBellicum Pharmaceuticals Inc
19/01/202306:30GlobeNewswire Inc.Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers SymposiumNASDAQ:BLCMBellicum Pharmaceuticals Inc
05/01/202312:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/12/202209:00GlobeNewswire Inc.Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with RimiducidNASDAQ:BLCMBellicum Pharmaceuticals Inc
18/11/202214:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BLCMBellicum Pharmaceuticals Inc
10/11/202215:05GlobeNewswire Inc.Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNASDAQ:BLCMBellicum Pharmaceuticals Inc
24/10/202215:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/10/202215:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BLCMBellicum Pharmaceuticals Inc
04/10/202206:30GlobeNewswire Inc.Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the MesaNASDAQ:BLCMBellicum Pharmaceuticals Inc
01/09/202206:30GlobeNewswire Inc.Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:BLCMBellicum Pharmaceuticals Inc
11/08/202215:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/08/202215:02GlobeNewswire Inc.Bellicum Reports Second Quarter 2022 Financial Results and Provides Operational UpdateNASDAQ:BLCMBellicum Pharmaceuticals Inc
24/05/202205:09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLCMBellicum Pharmaceuticals Inc
13/05/202215:15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BLCMBellicum Pharmaceuticals Inc
12/05/202215:05GlobeNewswire Inc.Bellicum Reports First Quarter 2022 Financial Results and Provides Operational UpdateNASDAQ:BLCMBellicum Pharmaceuticals Inc
29/04/202215:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BLCMBellicum Pharmaceuticals Inc
24/03/202215:05GlobeNewswire Inc.Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational UpdateNASDAQ:BLCMBellicum Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:BLCM

Su Consulta Reciente

COIN
MBOXUST
Mobox
LSE
XUCS
Xm Usa Con Stpl
EU
3706T
3706T
COIN
QBZUST
AMEX
TPS
CSE
METL
Metalite Resources
TSXV
SUS
GATE
CAKEETH
PancakeSwap Token
NASDAQ
AAZKHXX
Goldman Sachs Bank Usa P...
AMEX
SSFI
Day Haganned Davis Rese ...
EU
IPASI
Lyxor PASI iNav
LSE
ZY67
Cred Ag Co.29
NASDAQ
KBWD
Invesco KBW High Dividen...
USOTC
MICCF
Millcom Swed Dep Rec (PK)
ASX
FXLKOC
KUCN
ZELIXUSDT
ZELIX
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados